Experts Explore Potential of Ozempic Microdosing for Health Beyond Weight Loss

Emerging research and anecdotal reports suggest GLP-1 drugs could offer benefits for brain health, inflammation, and chronic conditions, but more trials are needed.

Ozempic and other GLP-1 drugs, primarily used for diabetes and weight loss, are being studied for broader health benefits, including brain health and reduced inflammation.
Preliminary trials indicate potential applications in treating Alzheimer's, liver disease, and addiction, as well as reducing cardiovascular risks even without weight loss.
Microdosing, or using lower-than-recommended doses, is gaining interest for preventive health and maintenance, though experts stress the need for clinical trials to confirm its efficacy and safety.
Side effects of GLP-1 drugs include nausea, digestive issues, and rare complications like pancreatitis, with long-term effects in non-obese users still uncertain.
Doctors emphasize the importance of medical supervision and caution against unregulated use, while pharmaceutical companies remain focused on approved indications.